Once thought to be a disease of middle and older age, hypertension is increasingly being recognized in young adults, often missed until complications arise. It brings its own challenges, from differentiating primary versus secondary causes to tackling myths that delay diagnosis and treatment.

In this session, Dr. Mahesh Shah will unmask the “silent killer” in the young, exploring its mechanisms, risk factors, and long-term consequences. Through clinical dilemmas and practical pearls, he will share strategies to identify hypertension early, manage it effectively, and prevent the far-reaching impact of untreated high blood pressure in this population.

Hypertension in Young Adults: Clinical Dilemmas and Pearls

Is aspirin truly the wonder drug we once believed it to be? In this eye-opening session, Dr. Mahesh K. Shah—an expert in cardiology—critically examines the evolving role of aspirin in clinical practice. From primary prevention to updated cardiovascular guidelines, this talk will explore new evidence that challenges long-held beliefs about aspirin's benefits and risks. Join us as Dr. Shah decodes recent data, discusses real-world implications, and offers clear guidance on when—and when not—to prescribe aspirin. A must-attend session for physicians navigating the shifting landscape of cardiovascular care.

Aspirin—Not the Lifesaver We Once Thought?

Is achieving extremely low LDL levels always beneficial, or can it pose risks? In this session, Renowned Interventional Cardiologist Dr. Mahesh K Shah dives into the nuanced science of extremely low LDL cholesterol—exploring its potential advantages, limitations, and clinical implications. Attendees will gain a clear understanding of when, why, and how to aim for very low LDL levels, supported by the latest evidence and therapeutic approaches. From primary prevention to managing high-risk cardiovascular patients, this session offers essential insights for making informed, patient-centered decisions.

Extremely Low LDL: Friend or Foe?

The "Best of Lipids Quiz" is a thought-provoking and educational event led by a distinguished panel of cardiologists and medical experts. Hosted by Medflix & Cipla, this quiz focuses on lipidology, an integral aspect of cardiovascular health, to deepen participants' understanding of lipid management and its implications for patient care.

Best of Lipids

Interventional Cardiologist at M K S Heart Care, Mumbai

Peri-operative cardiac risk assessment is often a balancing act—identifying patients who need further evaluation without delaying necessary surgery or subjecting patients to unnecessary investigations and interventions. The challenge becomes even greater when deciding whether revascularization or medical optimization is warranted before a non-cardiac procedure.

This session will provide a practical, evidence-based approach to pre-operative cardiovascular evaluation and risk stratification. The discussion will cover when cardiac testing is indicated, how to assess functional capacity and surgical risk, when coronary revascularization should be considered, and how to optimize patients with conditions such as coronary artery disease, heart failure, arrhythmias, and valvular disease. The focus will be on making clear clinical decisions while avoiding unnecessary testing, delays, and interventions.

Dr. Mahesh K Shah

6

4k

76.7k

4.8

Upcoming Sessions

Sessions Taken

2.4k

4.8

1.3k

4.8

1.4k

4.7

92

5